Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy
May 18, 2017 at 23:51 PM EDT
SEOUL (Reuters) - A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.
